0001193125-23-064972.txt : 20230309 0001193125-23-064972.hdr.sgml : 20230309 20230308214257 ACCESSION NUMBER: 0001193125-23-064972 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230308 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 23718019 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Schilke Tobin CENTRAL INDEX KEY: 0001678984 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, #371 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001678984 XXXXXXXX LIVE 0001479290 Revance Therapeutics, Inc. 001-36297 1222 Demonbreun St Suite 2000 Nashville TN 37203 615-724-7755 Tobin Schilke Officer COMMON E*TRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005 20000 660000.00 82800000 03/08/2023 NASD Revance Common 03/07/2023 RSU Vesting Revance Therapeutics N 20000 03/07/2023 cash N Tobin Schilke 1222 Demonbruen St Suite 2000 Nashville TN 37203 Revance Common 01/09/2023 3701 100525.00 Tobin Schilke 1222 Demonbruen St Suite 2000 Nashville TN 37203 Revance Common 01/20/2023 1000 31000.00 Tobin Schilke 1222 Demonbruen St Suite 2000 Nashville TN 37203 Revance Common 02/01/2023 3201 110755.00 Tobin Schilke 1222 Demonbruen St Suite 2000 Nashville TN 37203 Revance Common 03/01/2023 3201 107234.00 Shares sold to cover taxes from a RSU vest 03/08/2023 /s/ Dwight Moxie, Attorney-in-Fact